Co-Chief Editors

Anne S. De Groot, M.D.
Director, TB/HIV Research Lab, Brown Medical School

David Thomas, M.D., J.D.
Professor and Chairman, Department of Surgery, Division of Correctional Medicine, NSU-COM

Deputy Editors

Joseph Bick, M.D.
Chief Medical Officer, California Medical Facility, California Department of Corrections

Renee Ridzon, M.D.
Senior Program Officer, HIV, TB, Reproductive Health, Bill & Melinda Gates Foundation

Bethany Weaver, D.O., M.P.H.
Acting Instructor, Univ. of Washington, Center for AIDS and STD Research

Associate Editors

Rick Altice, M.D.
Director of Clinical Research, Director, HIV in Prisons Program, Director, Community Health Care Van, Associate Professor of Medicine, Yale University AIDS Program

David Paar, M.D.
Associate Professor of Medicine, University of Texas, Medical Branch

Karl Brown, M.D., F.A.C.P.
Infectious Disease Supervisor, PHS-Rikers Island

Ralf Jürgens
Consultant, HIV/AIDS, Human Rights, Drug Policy and Prisons

Joseph Paris, Ph.D., M.D., F.S.C.P., C.C.H.P.
Medical Director, Georgia Dept. of Corrections

Lester Wright, M.D., M.P.H.
Chief Medical Officer, New York State Dept. of Correctional Services

Dean Rieger, M.D.
Medical Director, Indiana Dept. of Corrections

Neil Fisher, M.D.
Medical Director, Chief Health Officer, Martin Correctional Institute

William Cassidy, M.D.
Associate Professor of Medicine, Louisiana State University Health Sciences Center

Editorial Board

Louis C. Tripoli, M.D., F.A.C.F.E.
Correctional Medical Institute, Correctional Medical Services

Josiah Rich, M.D.
Associate Professor of Medicine and Community Health Brown University School of Medicine, The Miriam Hospital

Steven F. Scheibel, M.D.
Regional Medical Director, Prison Health Services, Inc.

David A. Wohl, M.D.
Associate Professor of Medicine, University of North Carolina AIDS Clinical Research Unit

Barry Zack, M.P.H.
Executive Director, Centerforce

Michelle Gaseau
The Corrections Connection

Layout

Kimberly Backlund-Lewis
The Corrections Connection

Distribution

Screened Images Multimedia

Managing Editor

Courney E. Colton
IDCR

Faculty Disclosure

In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the faculty for this activity have been asked to complete Conflict of Interest Disclosure forms. Disclosures are listed at the end of articles. All of the individual medications discussed in this newsletter are approved for treatment of HIV and hepatitis unless otherwise indicated. For the treatment of HIV and hepatitis infection, many physicians opt to use combination antiretroviral therapy which is not addressed by the FDA.

Supporters

IDCR is grateful for the support of the following companies through unrestricted educational grants:

• Major Support: Abbott Laboratories, Boehringer Ingelheim and Roche Pharmaceuticals

• Sustaining: Pfizer Inc., Gilead Sciences Inc., GlaxoSmithKline, Merck & Co., Schering-Plough and ViroLogic.